Clinical Trial

Clinical Study of Cizutamig in Systemic Lupus Erythematosus

Name: Clinical Study of Cizutamig in Systemic Lupus Erythematosus — clinical trial record (NCT07215663)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

The purpose of this study is to assess the safety, tolerability, PK, PD, immunogenicity, and preliminary clinical activity of Cizutamig in patients with Systemic Lupus Erythematosus

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2025-10-02.

Status change: Not Yet Recruiting → Recruiting 2025-11-13

Trial Details

NCT Number	NCT07215663
Lead Sponsor	Candid Therapeutics
Conditions	Systemic Lupus Erythematosus (SLE)
Enrollment	47 participants
Start Date	2025-09-04
Primary Completion	2027-12 (estimated)
Study Completion	2028-04 (estimated)
Updated on ClinicalTrials.gov	2025-11-17